Embla Medical hf

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: IS0000000040
DKK
36.80
0.6 (1.66%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Embla Medical hf Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
601.00
500.00
395.00
542.00
81.00
600.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-60.00
-91.00
-157.00
-131.00
167.00
-144.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
800.00
650.00
430.00
632.00
603.00
636.00
Cash Flow from Investing Activities
-788.00
-393.00
-469.00
-374.00
-712.00
-418.00
Cash Flow from Financing Activities
106.00
-282.00
26.00
-321.00
355.00
-193.00
Net Cash Inflow / Outflow
93.00
-27.00
-60.00
-108.00
286.00
19.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-24.00
-1.00
-48.00
-45.00
39.00
-4.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in DKK Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Embla Medical hf
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(DKK)
Change(%)
Profit Before Tax
601.444142213136
300
301.00
100.48%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-60.1906139135144
-114
54.00
47.20%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
800.33036939924
813
-13.00
-1.56%
Cash Flow from Investing Activities
-788.966624213139
-289
-499.00
-173.00%
Cash Flow from Financing Activities
106.25239658533
-65
171.00
263.47%
Net Cash Inflow / Outflow
93.171677763708
458
-365.00
-79.66%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-24.4444640077224
-1
-23.00
-2344.45%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
stock-summary

YoY Growth in year ended Dec 2024 is 23.11% vs 51.12% in Dec 2023

Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
800.33
650.08
23.11%